Explore the Global Ophthalmic Biologics Market— analysis of key trends, regional growth, top players, and a 10-year forecast from 2026 to 2036.

The ophthalmic biologics market is projected to grow from USD 23.2 billion in 2026 to USD 51.0 billion by 2036, at a CAGR of 8.2%. Anti-VEGF therapies will dominate with a 62.0% market share, while amd will lead the applications segment with a 48.0% share.

January 13, 2026

Anurag Sharma

250 Pages

Cite this Report

Ophthalmic Biologics Market

https://www.futuremarketinsights.com/reports/ophthalmic-biologics-market

License

Starting at US$ 5000

Buy Now

Summary ToC Infographics Companies

Infographics

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Ophthalmic Biologics Market

Thank you!

You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.

Share Image Code

Get Image Code

Ophthalmic Biologics Market

Infographics

Similar Industry Reports